Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine. uri icon

Overview

publication date

  • July 15, 2011

Research

keywords

  • Azacitidine
  • DNA Methylation
  • DNA-Binding Proteins
  • Mutation
  • Myelodysplastic Syndromes
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2

Identity

Scopus Document Identifier

  • 83555165094

Digital Object Identifier (DOI)

  • 10.1038/leu.2011.170

PubMed ID

  • 21760590

Additional Document Info

volume

  • 25

issue

  • 12